| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
|
Cell
|
2009
|
7.09
|
|
2
|
Profiling critical cancer gene mutations in clinical tumor samples.
|
PLoS One
|
2009
|
5.63
|
|
3
|
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
|
J Clin Oncol
|
2009
|
2.94
|
|
4
|
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
|
J Natl Cancer Inst
|
2009
|
2.53
|
|
5
|
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
2.13
|
|
6
|
Differential requirement of mTOR in postmitotic tissues and tumorigenesis.
|
Sci Signal
|
2009
|
1.47
|
|
7
|
Identification of prostate cancer risk categories according to surgical margins status, pathological stage and Gleason score.
|
Int J Urol
|
2013
|
1.43
|
|
8
|
Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings.
|
Surgery
|
2004
|
1.42
|
|
9
|
mRNA expression signature of Gleason grade predicts lethal prostate cancer.
|
J Clin Oncol
|
2011
|
1.40
|
|
10
|
Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.
|
J Clin Oncol
|
2011
|
1.39
|
|
11
|
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
|
J Clin Oncol
|
2010
|
1.37
|
|
12
|
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis.
|
Am J Pathol
|
2010
|
1.30
|
|
13
|
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.
|
Transplantation
|
2004
|
1.27
|
|
14
|
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells.
|
J Pathol
|
2012
|
1.22
|
|
15
|
Establishment and genomic characterization of mouse xenografts of human primary prostate tumors.
|
Am J Pathol
|
2010
|
1.15
|
|
16
|
Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.
|
Glycobiology
|
2003
|
1.13
|
|
17
|
Genetic variation in RNASEL associated with prostate cancer risk and progression.
|
Carcinogenesis
|
2010
|
1.12
|
|
18
|
Gleason grade progression is uncommon.
|
Cancer Res
|
2013
|
1.09
|
|
19
|
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.
|
Onco Targets Ther
|
2013
|
1.08
|
|
20
|
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.
|
Inflamm Bowel Dis
|
2005
|
1.06
|
|
21
|
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.04
|
|
22
|
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry.
|
J Clin Pathol
|
2012
|
1.03
|
|
23
|
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.03
|
|
24
|
Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.03
|
|
25
|
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.
|
Am J Clin Pathol
|
2008
|
1.02
|
|
26
|
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.02
|
|
27
|
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.
|
J Natl Cancer Inst
|
2013
|
0.97
|
|
28
|
Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease.
|
Alcohol Alcohol
|
2002
|
0.94
|
|
29
|
Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.93
|
|
30
|
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis.
|
Biochem Biophys Res Commun
|
2010
|
0.93
|
|
31
|
Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study.
|
Hepatology
|
2002
|
0.89
|
|
32
|
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
|
Prostate
|
2015
|
0.88
|
|
33
|
Primary paraganglioma strictly confined to the liver and mimicking hepatocellular carcinoma: an immunohistochemical and in situ hybridization study.
|
Am J Surg Pathol
|
2002
|
0.86
|
|
34
|
Clinical significance of BRAF mutation in thyroid papillary cancer.
|
Otolaryngol Head Neck Surg
|
2013
|
0.86
|
|
35
|
CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer.
|
Mod Pathol
|
2012
|
0.84
|
|
36
|
The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy.
|
Urol Oncol
|
2009
|
0.84
|
|
37
|
Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry.
|
Diagn Mol Pathol
|
2008
|
0.83
|
|
38
|
Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
|
BJU Int
|
2013
|
0.83
|
|
39
|
A histopathologic screening method for rational use of organs from prostate-specific antigen-positive multiorgan donors: the Italian Emilia-Romagna Region experience.
|
Transplantation
|
2004
|
0.81
|
|
40
|
Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells.
|
Am J Pathol
|
2013
|
0.81
|
|
41
|
Inguinal canal tumors of adulthood.
|
Anticancer Res
|
2013
|
0.81
|
|
42
|
β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
|
Am J Clin Pathol
|
2011
|
0.81
|
|
43
|
Differing risk of cancer death among patients with pathologic T3a renal cell carcinoma: identification of risk categories according to fat infiltration and renal vein thrombosis.
|
Clin Genitourin Cancer
|
2013
|
0.80
|
|
44
|
Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
|
Liver Transpl
|
2008
|
0.80
|
|
45
|
Liver transplantations with donors aged 60 years and above: the low liver damage strategy.
|
Transpl Int
|
2008
|
0.80
|
|
46
|
Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.
|
J Hepatol
|
2004
|
0.79
|
|
47
|
Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings.
|
Clin Nucl Med
|
2014
|
0.79
|
|
48
|
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.
|
Virchows Arch
|
2011
|
0.79
|
|
49
|
Quantification of free plasma DNA before and after chemotherapy in patients with advanced epithelial ovarian cancer.
|
Diagn Mol Pathol
|
2008
|
0.78
|
|
50
|
Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors.
|
Histol Histopathol
|
2011
|
0.77
|
|
51
|
A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort.
|
Endocrine
|
2011
|
0.77
|
|
52
|
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance.
|
Transplantation
|
2008
|
0.77
|
|
53
|
The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: a retrospective study.
|
Dig Liver Dis
|
2013
|
0.77
|
|
54
|
Apoptosis in alcoholic hepatitis.
|
J Hepatol
|
2002
|
0.76
|
|
55
|
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples.
|
Diagn Mol Pathol
|
2009
|
0.75
|
|
56
|
[Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer].
|
Urologia
|
2012
|
0.75
|
|
57
|
Virologic and genetic evaluation of vemurafenib-induced skin cancers.
|
Cutan Ocul Toxicol
|
2014
|
0.75
|
|
58
|
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors.
|
Anticancer Drugs
|
2016
|
0.75
|
|
59
|
A retrospective study to reduce prostate biopsy cores by a real time interactive tool.
|
Arch Ital Urol Androl
|
2010
|
0.75
|
|
60
|
The Italian multiorgan donor cancer screening protocol: 2002-2005 experience.
|
Transplantation
|
2008
|
0.75
|
|
61
|
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease.
|
Pathology
|
2014
|
0.75
|
|
62
|
Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study.
|
Appl Immunohistochem Mol Morphol
|
2016
|
0.75
|
|
63
|
Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation.
|
Diagn Mol Pathol
|
2005
|
0.75
|
|
64
|
Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis.
|
Melanoma Res
|
2015
|
0.75
|
|
65
|
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections.
|
Diagn Mol Pathol
|
2005
|
0.75
|